Characteristics
|
Genotyping patterns
|
OR (95% CI)
|
p-value
|
---|
|
Clustered
|
Unique
| | |
---|
Gender
| | | | |
Male
|
63
|
79
|
0.9 (0.6-1.6)
|
0.791
|
Female
|
47
|
55
|
1
| |
Age group
(
years
)
| | | | |
≤ 45
|
93
|
117
|
0.8 (0.4-1.6)
|
0.534
|
>45
|
17
|
17
|
1
| |
Address
| | | | |
Rural
|
52
|
60
|
1.1 (0.7-1.8)
|
0.697
|
Urban
|
58
|
74
|
1
| |
Religion
| | | | |
Christian
|
108
|
130
|
1.7(0.3-9.2)
|
0.693*
|
Muslim
|
2
|
4
|
1
| |
Previous TB treatment
| | | | |
Yes
|
26
|
17
|
2.1(1.1-4.2)
|
0.026
|
No
|
84
|
117
|
1
| |
HIV status
| | | | |
Positive
|
24
|
38
|
0.7 (0.4-1.3)
|
0.243
|
Negative
|
86
|
96
|
1
| |
Isoniazid
| | | | |
Resistant
|
22
|
12
|
2.5 (1.2-5.4)
|
0.013
|
Sensitive
|
88
|
122
|
1
| |
Rifampicin
| | | | |
Resistant
|
9
|
5
|
2.3 (0.7-7.1)
|
0.137
|
Sensitive
|
101
|
129
|
1
| |
Streptomycin
| | | | |
Resistant
|
19
|
7
|
3.8(1.5-9.4)
|
0.002
|
Sensitive
|
91
|
127
|
1
| |
Ethambutol
| | | | |
Resistant
|
14
|
4
|
4.7 (1.5-14.9)
|
0.004
|
Sensitive
|
96
|
130
|
1
| |
Pyrazinamid
| | | | |
Resistant
|
8
|
4
|
2.5(0.7-8.7)
|
0.123
|
Sensitive
|
102
|
130
|
1
| |
Resistant to one or more FLD
| | | | |
Resistant
|
25
|
15
|
2.3(1.2-4.7)
|
0.015
|
Sensitive
|
85
|
119
|
1
| |
MDR-TB
| | | | |
Yes
|
8
|
4
|
2.5(0.7-8.7)
|
0.123
|
No
|
102
|
130
|
1
| |
Resistant to all FLD
| | | | |
Yes
|
8
|
1
|
10.4 (1.3-84.7)
|
0.012*
|
No
|
102
|
133
|
1
| |
M. tuberculosis
lineages
| | | | |
Dehli/CAS
|
51
|
44
|
6.2 (1.7-22.6)
|
0.006
|
Ethiopia_3
|
23
|
9
|
13.6(3.2-58.3)
|
<0.001
|
Haarlem
|
9
|
12
|
4.0(0.9-18.0)
|
0.071
|
Ethiopia_1§
|
3
|
16
|
1
|
-
|
Ethiopia_H37Rv like
|
9
|
8
|
6.0 (1.3-28.5)
|
0.024
|
Ethiopia_2
|
4
|
5
|
4.3 (0.7-25.9)
|
0.115
|
URAL
|
0
|
8
|
-
|
-
|
LAM
|
3
|
5
|
3.2(0.5-21.2)
|
0.228
|
TUR
|
4
|
1
|
21.3(1.7- 263.7)
|
0.017
|
X-type
|
0
|
3
|
-
|
-
|
S-type
|
0
|
2
|
-
|
-
|
Beijing
|
0
|
1
|
-
|
-
|
UgandII
|
0
|
1
|
-
|
-
|
Not defined
|
4
|
19
|
1.1(0.2-5.8)
|
0.890
|
Total
|
110 (45.1)
|
134 (54.9)
|
-
|
-
|
- *=Fisher exact test, FLD= First line anti-TB drugs, MDR= Multidrug resistant, §= reference category, LAM= M. tuberculosis Latin American Mediterranean.